Newsroom

Group picture
Story
Results of the nationwide antibody study
From July 2020 to August 2021, a research team from the HZI, with external support, studied the antibody status of more than 26,000 people in seven county districts and thus collected important data on the pandemic event.
02.12.2021
HZI Campus
buch
Story
“There will be other, perhaps even more dangerous pandemics”
Though the Corona pandemic is not over yet, we should already start preparing for future pandemics. A look at what infection research can contribute.
02.12.2021
HZI Campus
HIOH
Immunfluoreszenz-Aufnahme der Lunge
News
COVID-19-related respiratory failure: Why patients require prolonged ventilation
30.11.2021
HIRI
Immunotherapy against hepatitis B
News
Who benefits from immunotherapy against hepatitis B?
Hepatitis B is a viral infection of the liver that can lead to cancer and organ failure. Antiviral therapies can suppress the infection, but a functional cure is rare. Novel immunotherapies may lead to an actual cure more often. However, it is still unclear which patients benefit most from these new therapies. Researchers at the Centre for Individualised Infection Medicine (CiiM), a joint institution of the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH), as well as the MHH and the German Center for Infection Research (DZIF), have now identified a biomarker that intends to enable predictions about the success of the therapy. The results were published in the scientific journal Gut.
25.11.2021
CiiM
Infection and immunity week
News
Joint symposium of HZI and McGill University on personalised infection medicine
The Helmholtz Centre for Infection Research (HZI) in Braunschweig and the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) at McGill University in Montréal, Canada, are organising a joint symposium on personalised infection medicine on 29 November. Three researchers from each of the two institutions will give lectures on various topics of personalised infection medicine. The keynote lecture will be given by Prof Ugur Sahin, co-founder and CEO of BioNTech SE. The symposium kicks off McGill University's “Infection and Immunity Week”, which celebrates its 200th anniversary this year. Interested scientists can register to follow the event online.
23.11.2021
HZI Campus
CiiM
HIRI
Filterplättchen
News
20 research, medical and pharmaceutical organizations call on G7 to step up action against antibiotic resistance
Ahead of the “World Antimicrobial Awareness Week” (November 18-24) 20 national and international organizations from academia, healthcare and the pharmaceutical industry appealed today to G7 governments to step up efforts to tackle the problem of growing antibiotic resistance. Their "Joint Statement on Strengthening the Antibiotic R&D Pipeline by Rewarding Innovation" stresses that only an approach involving both the public and private sectors is likely to succeed. The Helmholtz Centre for Infection Research (HZI) is a member of the Helmholtz Association of German Research Centres and the German Center for Infection Research (DZIF), which both signed the statement.
17.11.2021
HZI Campus

HZI in the media

Polio-Wildviren im Abwasser nachgewiesen, aber geringes Infektionsrisiko für die Bevölkerung

Klett-Tammen, Abteilung Epidemiologie (EPID), Helmholtz-Zentrum für Infektionsforschung (

 

HZI

 

), Braunschweig. Grundsätzlich sei auch die ...

13.11.2025
|
Deutsches Ärzteblatt
Internationale Drehscheibe für Life Sciences in Tirol

von Angios in Innsbruck & wissenschaftlicher Geschäftsführer Helmholtz-Zentrum für Infektionsforschung in Braunschweig/Deutschland), Klaus

13.11.2025
|
meinbezirk.at
Die anderthalb Kilogramm schwere WG in unserem Darm

... zu adressieren, suchen Forschende am HZI-Standort Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) im Rahmen ...

13.11.2025
|
Prophylaxe Journal
Super-resolution microscopes showcase the inner lives of cells

new antiviral medicines, says virologist Christian Sieben of the Helmholtz Centre for Infection Research in Germany.

 

Earlier in 2025, for

10.11.2025
|
The Press
KI-Update Deep-Dive: Wie CAIMed Diagnosen verbessern will

Hochschule Hannover, die Universitätsmedizin Göttingen, das Helmholtz-Zentrum für Infektionsforschung in Braunschweig sowie die KI-

07.11.2025
|
Heise online
Vitalpilze – die neuen Wundermittel? Von wegen!

... , Leiter der Forschungsgruppe Mikrobielle Wirkstoffe am Helmholtz-Zentrum für Infektionsforschung, zu bedenken. Das erste ...

07.11.2025
|
Leipziger Volkszeitung (LVZ)
Malaria: Neuer Wirkstoff dreht dem Parasiten den Protein-Hahn zu

Quelle: Pressemitteilung

 

HZI-Helmholtz Zentrum für Infektionsforschung ...

04.11.2025
|
LaborPraxis
Grippe-Schnelltest per Kaugummi

Forschende des Helmholtz-Zentrums für Infektionsforschung und der Universität Würzburg entwickeln derzeit einen Kaugummi, der Grippeviren

04.11.2025
|
Arbeitsmedizin-Sozialmedizin-Umweltmedizin
Eier und Geflügel gefahrlos verzehren? So können sich Menschen vor der Vogelgrippe schützen

... Vakzinologie und angewandte Mikrobiologie am Helmholtz-Zentrum für Infektionsforschung. Die M2-Membranproteinhemmer verhindern ...

02.11.2025
|
Augsburger Allgemeine
Pilze für die Gesundheit – was können „Vitalpilze“?

... etwas dran ist“, erklärt Biologe Marc Stadler vom Helmholtz-Zentrum für Infektionsforschung gegenüber der Barmer-Krankenkasse. „Es ...

30.10.2025
|
bild der wissenschaft
Vaccinated against polio—or not? Study finds differences between documented and self-reported vaccination rates

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025
|
MSN.com
Gegen Polio Geimpft: Fakten Und Mythen Im Überblick

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025
|
innovations report

Register now for the HZI-Newsletter